Top Analysts Pick 3 Stocks to Buy Now: WIX, DDOG, and CTNM
ByAinvest
Wednesday, Aug 20, 2025 7:34 pm ET1min read
CTNM--
Wix.com Ltd. (WIX)
Wix.com, a leading cloud-based web development platform, has drawn significant attention from analysts. JMP Securities recently raised its price target for WIX from $160 to $200, indicating a potential upside of 54.58% from the current stock price [1]. This positive outlook is supported by a consensus rating of "Buy" and an average target price of $215.63, with 15 out of 17 top analysts recommending a buy rating.
The company's recent financial performance has been robust, with earnings per share (EPS) of $2.28 for the quarter, exceeding the consensus estimate of $1.79. Additionally, Wix.com announced a share repurchase plan to repurchase up to $200 million in shares, reflecting confidence in the company's valuation [1].
Datadog (DDOG)
Datadog, a cloud-based monitoring and analytics platform, has also received strong analyst support. The company has a 25.19% upside potential with 25 out of 29 top analysts recommending a buy rating. Analysts have cited Datadog's growing customer base and strong revenue growth as key drivers for the positive outlook.
Continuum Therapeutics (CTNM)
Continuum Therapeutics, a biotechnology company, has been identified as having the highest upside potential among the three stocks. All three top analysts recommend a buy rating, with a potential upside of 171.6%. The company's innovative approach to cancer therapy and strong clinical trial results have garnered analyst interest.
Conclusion
Wix.com, Datadog, and Continuum Therapeutics have been recognized for their significant upside potential by top analysts. Investors should closely monitor these companies for potential growth opportunities.
References
[1] https://www.marketbeat.com/instant-alerts/wixcom-nasdaqwix-stock-price-expected-to-rise-jmp-securities-analyst-says-2025-08-18/
[2] https://www.ainvest.com/news/wix-upgraded-buy-cfra-analyst-sets-price-target-159-2508/
DDOG--
WIX--
Three stocks with significant upside potential, according to top analysts, are Wix.com Ltd. (WIX), Datadog (DDOG), and Continuum Therapeutics (CTNM). WIX has a 57.28% upside potential with 15 out of 17 top analysts recommending a buy, while DDOG has a 25.19% upside potential with 25 out of 29 top analysts recommending a buy. CTNM has a 171.6% upside potential with all three top analysts recommending a buy.
Three stocks with notable upside potential, according to top analysts, are Wix.com Ltd. (WIX), Datadog (DDOG), and Continuum Therapeutics (CTNM). These companies have been highlighted for their strong analyst support and growth prospects.Wix.com Ltd. (WIX)
Wix.com, a leading cloud-based web development platform, has drawn significant attention from analysts. JMP Securities recently raised its price target for WIX from $160 to $200, indicating a potential upside of 54.58% from the current stock price [1]. This positive outlook is supported by a consensus rating of "Buy" and an average target price of $215.63, with 15 out of 17 top analysts recommending a buy rating.
The company's recent financial performance has been robust, with earnings per share (EPS) of $2.28 for the quarter, exceeding the consensus estimate of $1.79. Additionally, Wix.com announced a share repurchase plan to repurchase up to $200 million in shares, reflecting confidence in the company's valuation [1].
Datadog (DDOG)
Datadog, a cloud-based monitoring and analytics platform, has also received strong analyst support. The company has a 25.19% upside potential with 25 out of 29 top analysts recommending a buy rating. Analysts have cited Datadog's growing customer base and strong revenue growth as key drivers for the positive outlook.
Continuum Therapeutics (CTNM)
Continuum Therapeutics, a biotechnology company, has been identified as having the highest upside potential among the three stocks. All three top analysts recommend a buy rating, with a potential upside of 171.6%. The company's innovative approach to cancer therapy and strong clinical trial results have garnered analyst interest.
Conclusion
Wix.com, Datadog, and Continuum Therapeutics have been recognized for their significant upside potential by top analysts. Investors should closely monitor these companies for potential growth opportunities.
References
[1] https://www.marketbeat.com/instant-alerts/wixcom-nasdaqwix-stock-price-expected-to-rise-jmp-securities-analyst-says-2025-08-18/
[2] https://www.ainvest.com/news/wix-upgraded-buy-cfra-analyst-sets-price-target-159-2508/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet